期刊文献+

抗癌药雷替曲塞的合成 被引量:12

Synthesis of anticancer drug raltitrexed
在线阅读 下载PDF
导出
摘要 目的研究抗癌药雷替曲塞的合成。方法以2-噻吩甲醛为起始原料,经硝化、氧化、酯化、还原、氨基保护、N-甲基化、水解、缩合、脱保护、N-烷基化、水解11步反应合成雷替曲塞。结果与结论总收率为12.9%,其结构经核磁共振氢谱、质谱确证。 Aim To study the synthesis of rahitrexed. Methods Rahitrexed was synthesized from 2-thiophenealdehyde via eleven steps of reaction, i. e., nitration, oxidation, esterification, reduction, amino-protection, Nmethylation, hydrolysis, condensation, deprotection, N-alkylation, and hydrolysis. Results and conclusion The total yield was 12.9%. The structure of the target compound was confirmed by 1H-NMR and MS spectra.
出处 《中国药物化学杂志》 CAS CSCD 2007年第6期368-371,共4页 Chinese Journal of Medicinal Chemistry
关键词 药物制备 化学合成 雷替曲塞 drug preparation chemical synthesis rahitrexed
作者简介 郝明春(1982-),男(汉族),吉林延边人,硕士研究生,E—mail:hmc19820113@yahoo.com; 董金华(1966-),男(汉族),江苏宝应人,研究员,博士生导师,主要从事药物化学研究,Tel(024)23986402,E-mail:dongjh66@hotmail.com
  • 相关文献

参考文献2

二级参考文献16

  • 1[1]Bavetsias, V.; Marriott, J. H.; Melin, C.; Kimbell, R.; Matusiak, Z. S.; Boyle, F. T.; Jackman, A. L. J. Med. Chem. 2000, 43, 1910.
  • 2[2]Cunningham, D.; Zalcberg, J.; Maroun, J.; James, R.; Clarke, S.; Maughan, T. S.; Vincent, M.; Schulz, J.; Baron, M. G.; Facchini, T. Eur. J. Cancer 2002, 38, 478.
  • 3[3]Marsham, P. R.; Hughes, L. R.; Jackman, A. L.; Hayter, A. J.; Oldfield, J.; Wardleworth, J. M.; Bishop, J. A. M.; O'Connor, B. M.; Calvert, A. H. J. Med. Chem. 1991, 34, 1594.
  • 4[4]Hughes, L. R. US 4992550, 1991.
  • 5Farrugia D C, Norman A R, Cunningham D. Single agent infusional 5-fluo rouracil is not effective second-line therapy after raltitrexed (Tomudex) in adva need colorectal cancer[J]. Eur J Cancer,1998,34(7) : 987-991.
  • 6Kohne C H, Thuss P P. Raltitrexed (Tomudex):An alternative drug for patients with colorectal cancer and 5-fluorouracil associatedcardiotoxicity[J]. Br J Cancer, 1998, 77(6):973-977.
  • 7Lohmeyer M, Castaner J. Tomudex^TM[J]. Drugs of the Future, 1995,20(4) : 371-375.
  • 8Marsham P R, Hughes L R, Jackman A L, et al. Quinalazoline antifolateth ymdiylate synthase inhibitors: Heterocyclic benzoyl ring modifications [J]. J Med Chem, 1991,34 (5):1 594-1 605.
  • 9Jones T R, Calvert A H. A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice[J]. Eur J Cancer,1981,17: 11-19.
  • 10Jones T R, Calif L J, Jackman A L, et al. Anti-canter quinazoline derivatives[P]. US:5236927,1993-08-17.

共引文献8

同被引文献102

引证文献12

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部